Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

CompletedOBSERVATIONAL
Enrollment

5,154

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

August 1, 2020

Study Completion Date

July 1, 2023

Conditions
Coronavirus Infection
Interventions
OTHER

No intervention

Observational

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Montefiore Medical Center

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

Baylor Health Care System

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

Cook County Hospital

OTHER

collaborator

The Cooper Health System

OTHER

collaborator

Duke University

OTHER

collaborator

Georgetown University

OTHER

collaborator

Hackensack mountainside hospital

UNKNOWN

collaborator

Hackensack Meridian Health

OTHER

collaborator

Indiana University Health Methodist Hospital

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Loma Linda University

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

Medical College of Wisconsin

OTHER

collaborator

Northwestern University

OTHER

collaborator

Weill Medical College of Cornell University

OTHER

collaborator

NYU Langone Health

OTHER

collaborator

Ochsner Health System

OTHER

collaborator

Oregon Health and Science University

OTHER

collaborator

Renown Health

OTHER

collaborator

Rush University Medical Center

OTHER

collaborator

New Jersey Medical School

OTHER

collaborator

Rutgers Robert Wood Johnson Medical School

OTHER

collaborator

Stanford University

OTHER

collaborator

Temple University

OTHER

collaborator

Tufts Medical Center

OTHER

collaborator

Tulane University

OTHER

collaborator

University of California, Davis

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

University Hospitals Cleveland Medical Center

OTHER

collaborator

University Medical Center of Southern Nevada

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

University of Chicago

OTHER

collaborator

University of Florida

OTHER

collaborator

University of Illinois at Chicago

OTHER

collaborator

University of Kentucky

OTHER

collaborator

University of Miami

OTHER

collaborator

University of Michigan

OTHER

collaborator

University of Oklahoma

OTHER

collaborator

University of Pennsylvania

OTHER

collaborator

University of Pittsburgh Medical Center

OTHER

collaborator

University of Tennessee

OTHER

collaborator

University of Washington

OTHER

collaborator

University of Texas, Southwestern Medical Center at Dallas

OTHER

collaborator

Yale University

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT04343898 - Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 | Biotech Hunter | Biotech Hunter